Ivermectin Controversies

Here is a collection of information regarding Ivermectin. It is not organized, but feel free to use it as it helps you figure out whether or not you feel comfortable using this drug as a preventative or as treatment for COVID-19. 

I personally took two 3mg pills a day for 5 days while I had COVID symptoms. I did not have any noticeable side effects from the doctor's prescription. 

The link listed on the above graphic is linked here

► Ivermectin Study in Africa - Reduces Mortality

Basically, they studied 2 groups:

Group 1: 31 countries using Ivermectin for treatment of Onchocerciasis (onco-sir-ky-asis) (black fly parasite that causes blindness, rashes, etc) ; MORBIDITY (disease rate and suffering) and MORTALITY (death) "were statistically significantly less"

Group 2: 22 countries that are not using Ivermectin (non-endemic); "The average life expectancy was statistically significantly higher in the non-endemic countries."

The recovery and fatality rates were not statistically significant difference.

"it is suggested that ivermectin being a well-known antiparasitic agent with antiviral activity and anti-inflammatory effects, has activity against SARS-CoV-2 [5]."

Ivermectin has been administered in Africa for onchocerciasis under the WHO strategy with the goal to elimination in 80% of countries by 2025.

"proving to be one of Africa’s most successful in reducing disease at low cost"

"Ivermectin is an approved antiparasitic drug that is used to treat several neglected tropical diseases, including onchocerciasis, helminthiases, and scabies. For these indications, ivermectin has been widely used and has demonstrated an excellent safety profile"

Table 3. Comparison between the two studied groups

Ivermectin vs Non-Ivermectin 

Average life expectancy (y/o) 60.7 ± 4.8 vs 66.4 ± 7.3 

Population (Million) 31.3 ± 41.0 vs  16.2 ± 24.7 

Morbidity per Million 926.4 ± 926.2 vs 6473.5 ± 7090.6 

Mortality per Million 14.4 ± 13.2 vs 121.9 ± 161.2 

Recovery rate (%) 78.1 ± 16.6 vs 78.0 ± 14.6 

Fatality rate (%) 2.1 ± 1.4 vs  2.0 ± 1.2 

"South African Health Products Regulatory Authority (SAHPRA) has given the green light for the controlled use of Ivermectin for humans on January 27, 2021. Since then, the number of new COVID-19 infections in South Africa has been declining."

----

"Firstly, we engaged with the WHO [World Health Organisation] and there’s a statement they’ve issued around this, saying there’s limited information around [the drug]. WHO is working to review current clinical trials for them to get sufficient data to give to us." Source

Jan 2021

On January 14, 2021, the NIH COVID-19 Treatment Guidelines were updated to reflect the latest studies on ivermectin. The updated recommendation was:

“The COVID-19 Treatment Guidelines Panel (the Panel) has determined that currently there are insufficient data to recommend either for or against the use of ivermectin for the treatment of COVID-19.”

That statement was a deception. A vote of the Panel to endorse that recommendation was never held.

The COVID-19 Treatment Guidelines were announced on April 21, 2020 to assist healthcare providers in treatment decisions in COVID-19. A group of 43 medical authorities and representatives of the community were assembled to produce the Guidelines. The NIH COVID-19 Treatment Guidelines are not legally binding to physicians or patients. As the Guidelines state:

“Finally, it is important to stress that the rated treatment recommendations in these Guidelines should not be considered mandates. The choice of what to do or not to do for an individual patient is ultimately decided by the patient and their provider.”

Source

March 2021

WHO advises that ivermectin only be used to treat COVID-19 within clinical trials

A guideline development group was convened in response to the increased international attention on ivermectin as a potential treatment for COVID-19.

This group is an

• independent,
• international panel of experts,
• clinical care experts in multiple specialties 
• ethicist and
• patient-partners.

The group reviewed pooled data from 16 randomized controlled trials (total enrolled 2407), including both inpatients and outpatients with COVID-19.

They determined that the evidence on whether ivermectin

• reduces mortality,
• need for mechanical ventilation,
• need for hospital admission and
• time to clinical improvement in COVID-19 patients

is of “very low certainty,” due to the small sizes and methodological limitations of available trial data, including small number of events. 

The panel did not look at the use of ivermectin to prevent COVID-19, which is outside of scope of the current guidelines.

• Strong recommendation against the use of hydroxychloroquine or chloroquine for treatment of COVID-19 of any severity  (see below link where Fauci admitted in 2005 HCQ worked against Coronoviruses)

SOURCE

April 2021

Dr Surya Kant said it was only after Australia started including Ivermectin in its protocol for COVID-19 treatment significantly, the WHO started thinking about the drug.

The World Health Organisation (WHO) recently recommended that antiparasitic drug Ivermectin must be used to treat COVID-19 patients within the clinical trials only.

Dr Surya Kant Tripathi – Head, Respiratory Medicine Department, King George Medical University, Lucknow – told Financial Express Online that Ivermectin is being used both for the treatment of coronavirus patients and as prophylaxis for COVID-19 for more than nine months without any major side effects being reported. Source

 JUNE 2021

(4) Notes the predicted and emerging empirical evidence of the impact of COVID-19 on NTD programmes and recommends that:

• medicines without proven evidence of efficacy against COVID-19 (e.g. azithromycin, ivermectin) be protected from being diverted for use against COVID-19, and that even in the event of efficacy of such drugs against COVID-19 being established, the agreement of medicine donors for repurposing be obtained before the donations are used for that purpose;

SOURCE 

Side Note:  Fauci admitted in 2005 HCQ and Azithromycin worked against COVID

HOW TO GET IVERMECTIN:

Compounding Pharmacies

Push Doctor Prescription

Ivermectin Clinical Trials  - This is a great resource to see how many different countries have been studying the effectiveness. Scroll to the bottom of the studies to see the results. 

FDA Ivermectin Label Insert

FDA Website Advice

Options for Preventing and Treating COVID-19

The most effective ways to limit the spread of COVID-19 include getting a COVID-19 vaccine when it is available to you and following current CDC guidance.

Talk to your health care provider about available COVID-19 vaccines and treatment options. Your provider can help determine the best option for you, based on your health history.

Source

IVERMECTIN listed on the WHO's ESSENTIAL DRUGS LIST

Ivermectin Black Market (source of the Blog image)

Ivermectin Conspiracy - Govt shutting it down

Pfizer Vaccine Details on Drugs Website